Benefit of first-pass complete reperfusion in thrombectomy is mediated by limited infarct growth.


Journal

European journal of neurology
ISSN: 1468-1331
Titre abrégé: Eur J Neurol
Pays: England
ID NLM: 9506311

Informations de publication

Date de publication:
01 2021
Historique:
received: 11 05 2020
accepted: 18 08 2020
pubmed: 9 9 2020
medline: 12 8 2021
entrez: 8 9 2020
Statut: ppublish

Résumé

The number of clot retrieval attempts required to achieve complete reperfusion by mechanical thrombectomy impacts functional outcome in acute ischaemic stroke (AIS). Complete reperfusion [expanded Treatment In Cerebral Infarction (eTICI) score = 3] at first pass (FP), is associated with the highest rates of favorable outcome compared to complete reperfusion by multiple passes. The aim of the present study was to investigate the relationship between FP complete reperfusion and infarct growth (IG). Anterior AIS patients with baseline and 24-h diffusion-weighted magnetic resonance imaging were included from two prospective registries. IG was measured by voxel-based segmentation of initial and 24-h diffusion-weighted imaging lesions. IG and favorable 3-month modified Rankin Scale (mRS) score (≤ 2) were compared between patients in whom complete reperfusion (eTICI 3) was achieved with a single pass (FP group) and those for whom multiple passes were required (MP group), after matching for confounding factors. Mediation analysis was performed to examine the association between FP and 3-month mRS score, with IG as mediating variable. A total of 200 patients were included, of whom 118 (28.9%) had FP complete reperfusion. In case-control analysis, the FP group had lower IG than the MP group [8.7 (5.4-12.9) ml vs. 15.2 (11-22.6) ml, respectively; P = 0.03). Favorable outcome was higher in the FP population compared to a matched MP population (70.9% vs. 53.2%, respectively; P = 0.04). FP compete reperfusion (eTICI 3) was independently associated with favorable outcome in multivariable regression analysis [odds ratio 1.86, 95% confidence interval (CI) 1.01-4.39; P = 0.04]. The effect of complete reperfusion at FP on functional outcome was explained by limited IG in mediation analysis [indirect effect: -0.32 (95% CI -0.47 to -0.09)]. Complete reperfusion at FP is independently associated with significant decrease in IG compared to complete reperfusion by multiple attempts, explaining better functional outcomes.

Sections du résumé

BACKGROUND AND PURPOSE
The number of clot retrieval attempts required to achieve complete reperfusion by mechanical thrombectomy impacts functional outcome in acute ischaemic stroke (AIS). Complete reperfusion [expanded Treatment In Cerebral Infarction (eTICI) score = 3] at first pass (FP), is associated with the highest rates of favorable outcome compared to complete reperfusion by multiple passes. The aim of the present study was to investigate the relationship between FP complete reperfusion and infarct growth (IG).
METHODS
Anterior AIS patients with baseline and 24-h diffusion-weighted magnetic resonance imaging were included from two prospective registries. IG was measured by voxel-based segmentation of initial and 24-h diffusion-weighted imaging lesions. IG and favorable 3-month modified Rankin Scale (mRS) score (≤ 2) were compared between patients in whom complete reperfusion (eTICI 3) was achieved with a single pass (FP group) and those for whom multiple passes were required (MP group), after matching for confounding factors. Mediation analysis was performed to examine the association between FP and 3-month mRS score, with IG as mediating variable.
RESULTS
A total of 200 patients were included, of whom 118 (28.9%) had FP complete reperfusion. In case-control analysis, the FP group had lower IG than the MP group [8.7 (5.4-12.9) ml vs. 15.2 (11-22.6) ml, respectively; P = 0.03). Favorable outcome was higher in the FP population compared to a matched MP population (70.9% vs. 53.2%, respectively; P = 0.04). FP compete reperfusion (eTICI 3) was independently associated with favorable outcome in multivariable regression analysis [odds ratio 1.86, 95% confidence interval (CI) 1.01-4.39; P = 0.04]. The effect of complete reperfusion at FP on functional outcome was explained by limited IG in mediation analysis [indirect effect: -0.32 (95% CI -0.47 to -0.09)].
CONCLUSION
Complete reperfusion at FP is independently associated with significant decrease in IG compared to complete reperfusion by multiple attempts, explaining better functional outcomes.

Identifiants

pubmed: 32896067
doi: 10.1111/ene.14490
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

124-131

Informations de copyright

© 2020 European Acadamy of Neurology.

Références

Badhiwala JH, Nassiri F, Alhazzani W, et al. Endovascular thrombectomy for acute ischemic stroke: a meta-analysis. JAMA 2015; 314: 1832-1843.
Saver JL, Goyal M, van der Lugt A, et al. Time to treatment with endovascular thrombectomy and outcomes from ischemic stroke: a meta-analysis. JAMA 2016; 316: 1279-1288.
Nogueira RG, Jadhav AP, Haussen DC, et al. Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. N Engl J Med 2018; 378: 11-21.
Seker F, Pfaff J, Wolf M, et al. Correlation of thrombectomy maneuver count with recanalization success and clinical outcome in patients with ischemic stroke. AJNR Am J Neuroradiol 2017; 38: 1368-1371.
Fabian Flottmann, Hannes Leischner, Gabriel Broocks, et al. Recanalization rate per retrieval attempt in mechanical thrombectomy for acute ischemic stroke. Stroke 2018; 49: 2523-2525.
Zaidat OO, Castonguay AC, Linfante I, et al. First pass effect: a new measure for stroke thrombectomy devices. Stroke 2018; 49: 660-666.
García-Tornel Á, Requena M, Rubiera M, et al. When to stop: detrimental effect of device passes in acute ischemic stroke secondary to large vessel occlusion. Stroke 2019; 50: 1781-1788.
Nikoubashman O, Dekeyzer S, Riabikin A, et al. True first-pass effect: first-pass complete reperfusion improves clinical outcome in thrombectomy stroke patients. Stroke 2019; 50: 2140-2146.
Kim SM, Kwon SU, Kim JS, et al. Early infarct growth predicts long-term clinical outcome in ischemic stroke. J Neurol Sci 2014; 347: 205-209.
Hassen WB, Tisserand M, Turc G, et al. Comparison between voxel-based and subtraction methods for measuring diffusion-weighted imaging lesion growth after thrombolysis. Int J Stroke Off J Int Stroke Soc 2016; 11: 221-228.
Greve DN, Fischl B. Accurate and robust brain image alignment using boundary-based registration. NeuroImage 2009; 48: 63-72.
Schönenberger S, Uhlmann L, Hacke W, et al. Effect of conscious sedation vs general anesthesia on early neurological improvement among patients with ischemic stroke undergoing endovascular thrombectomy: a randomized clinical trial. JAMA 2016; 316: 1986-1996.
Hacke W, Kaste M, Bluhmki E, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008; 359: 1317-1329.
von Elm E, Altman DG, Egger M, et al. Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ 2007; 335: 806-808.
Simonsen CZ, Mikkelsen IK, Karabegovic S, et al. Predictors of infarct growth in patients with large vessel occlusion treated with endovascular therapy. Front Neurol 2017; 8: 574.
Man S, Aoki J, Hussain MS, et al. Predictors of infarct growth after endovascular therapy for acute ischemic stroke. J Stroke Cerebrovasc Dis 2015; 24: 401-407.
Son JP, Lee MJ, Kim SJ, et al. Impact of slow blood filling via collaterals on infarct growth: comparison of mismatch and collateral status. J Stroke 2017; 19: 88-96.
Hayes AF, Rockwood NJ. Regression-based statistical mediation and moderation analysis in clinical research: observations, recommendations, and implementation. Behav Res Ther 2017; 98: 39-57.
Li Z, Zhou T, Li Y, et al. Anemia increases the mortality risk in patients with stroke: a meta-analysis of cohort studies. Sci Rep 2016; 6: 26636.
Mokin M, Fargen KM, Primiani CT, et al. Vessel perforation during stent retriever thrombectomy for acute ischemic stroke: technical details and clinical outcomes. J Neurointerventional Surg 2017; 9: 922-928.
Chueh J-Y, Puri AS, Wakhloo AK, et al. Risk of distal embolization with stent retriever thrombectomy and ADAPT. J Neurointerventional Surg 2016; 8: 197-202.
Brinjikji W, Starke RM, Murad MH, et al. Impact of balloon guide catheter on technical and clinical outcomes: a systematic review and meta-analysis. J Neurointerventional Surg 2018; 10: 335-339.
Zaidat OO, Mueller-Kronast NH, Hassan AE, et al. Impact of balloon guide catheter use on clinical and angiographic outcomes in the STRATIS stroke thrombectomy registry. Stroke 2019; 50: 697-704.
Bellwald S, Balasubramaniam R, Nagler M, et al. Association of anemia and hemoglobin decrease during acute stroke treatment with infarct growth and clinical outcome. PLoS One 2018; 13: e0203535.
Kellert L, Martin E, Sykora M, et al. Cerebral oxygen transport failure?: decreasing hemoglobin and hematocrit levels after ischemic stroke predict poor outcome and mortality: STroke: RelevAnt Impact of hemoGlobin, Hematocrit and Transfusion (STRAIGHT)-an observational study. Stroke 2011; 42: 2832-2837.
Kleine JF, Wunderlich S, Zimmer C, et al. Time to redefine success? TICI 3 versus TICI 2b recanalization in middle cerebral artery occlusion treated with thrombectomy. J NeuroInterventional Surg 2017; 9: 117-121.
Dargazanli C, Fahed R, Blanc R, et al. Modified thrombolysis in cerebral infarction 2C/thrombolysis in cerebral infarction 3 reperfusion should be the aim of mechanical thrombectomy: insights from the ASTER trial (contact aspiration versus stent retriever for successful revascularization). Stroke 2018; 49: 1189-1196.
Liebeskind DS, Bracard S, Guillemin F, et al. eTICI reperfusion: defining success in endovascular stroke therapy. J NeuroInterventional Surg 2019; 11: 433-438.
Ducroux C, Piotin M, Gory B, et al. First pass effect with contact aspiration and stent retrievers in the Aspiration versus Stent Retriever (ASTER) trial. J NeuroInterventional Surg 2020; 12: 386-391.
Rabinstein AA, Albers GW, Brinjikji W, et al. Factors that may contribute to poor outcome despite good reperfusion after acute endovascular stroke therapy. Int J Stroke 2019; 14: 23-31.
Haussen DC, Nogueira RG, Elhammady MS, et al. Infarct growth despite complete reperfusion in endovascular therapy for acute ischemic stroke. J NeuroInterventional Surg 2016; 8: 117-121.
Campbell BCV, Mitchell PJ, Kleinig TJ, et al. Endovascular therapy for ischemic stroke with perfusion-imaging selection. N Engl J Med 2015; 372: 1009-1018.
Albers GW, Marks MP, Kemp S, et al. Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging. N Engl J Med 2018; 378: 708-718.
Simonsen CZ, Yoo AJ, Rasmussen M, et al. Magnetic resonance imaging selection for endovascular stroke therapy: workflow in the GOLIATH trial. Stroke 2018; 49: 1402-1406.
Provost C, Soudant M, Legrand L, et al. Magnetic resonance imaging or computed tomography before treatment in acute ischemic stroke: effect on workflow and functional outcome. Stroke 2019; 50: 659-664.
Kannath SK, Rajan JE, Sylaja PN, et al. Dwell time of stentriever influences complete revascularization and first-pass TICI 3 revascularization in acute large vessel occlusive stroke. World Neurosurg 2018; 110: 169-173.

Auteurs

W Ben Hassen (W)

INSERM UMR 1266, Department of Neuroradiology, Université de Paris, Paris, France.

M Tordjman (M)

INSERM UMR 1266, Department of Neuroradiology, Université de Paris, Paris, France.

G Boulouis (G)

INSERM UMR 1266, Department of Neuroradiology, Université de Paris, Paris, France.

M Bretzner (M)

Department of Interventional Neuroradiology, University of Lille, CHU Lille, Lille, France.

N Bricout (N)

Department of Interventional Neuroradiology, University of Lille, CHU Lille, Lille, France.

L Legrand (L)

INSERM UMR 1266, Department of Neuroradiology, Université de Paris, Paris, France.

J Benzakoun (J)

INSERM UMR 1266, Department of Neuroradiology, Université de Paris, Paris, France.

M Edjlali (M)

INSERM UMR 1266, Department of Neuroradiology, Université de Paris, Paris, France.

P Seners (P)

Department of Neurology, CH Sainte-Anne, Paris, France.

C Cordonnier (C)

Department of Vascular Neurology, Stroke Unit, University of Lille, CHU Lille, Lille, France.

C Oppenheim (C)

INSERM UMR 1266, Department of Neuroradiology, Université de Paris, Paris, France.

G Turc (G)

Department of Neurology, CH Sainte-Anne, Paris, France.

H Henon (H)

Department of Vascular Neurology, Stroke Unit, University of Lille, CHU Lille, Lille, France.

O Naggara (O)

INSERM UMR 1266, Department of Neuroradiology, Université de Paris, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH